Mylan Pantoprazole 20mg. 40mg Enteric-coated tablets
PDF Leaflet Revision Date: 15 January 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of duodenal ulcer, gastric ulcer, and reflux oesophagitis.
Dosage (summary)
20 mg once daily for mild GERD; 40 mg once daily for ulcers.
Onset of Action / Duration
Onset: 2.5 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Atazanavir
- Ketoconazole
- Ampicillin esters
- Iron salts
Contraindications
- Hypersensitivity to pantoprazole
- Severe liver impairment
- Children
Common side effects
- Headache
- Diarrhoea
- Constipation
- Nausea
Counselling Points
- Take before breakfast
- Swallow whole
- Report any severe side effects
Serious warnings
- Monitor liver enzymes in severe impairment
- Risk of interstitial nephritis
- Exclude malignancy before treatment
Important Disclaimer
The Mylan Pantoprazole 20mg. 40mg Enteric-coated tablets professional information leaflet below is the property of Xixia Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
